Displaying 1 - 20 of 54
A 10-Year Projection of the Prescription Drug Share of National Health Expenditures, Including Nonretail
May 24, 2017
The latest forecast of national health expenditures (NHE) by the Centers for Medicare & Medicaid Services (CMS) has prescription drug spending comprising 10.1% of national health spending in 2015 and increasing to 10.8% in 2025.
Who benefits from manufacturer drug rebates? A new report from the Altarum Center for Value in Health Care examines the impact of behind-the-scenes rebates on both health plans and consumers.